UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 18, 2016
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) | ||
| MICHIGAN | 0-17988 | 38-2367843 | ||
| 620 Lesher Place Lansing, Michigan | 48912 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code 517-372-9200
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 18, 2016, Neogen Corporation (Nasdaq: NEOG) announced that Dr. Richard Crowder has resigned as a member of the company’s Board of Directors, effective April 30. Crowder, 77, resigned for personal reasons.
Crowder has been a member of the Board of Directors since 2009 and was elected to a new three-year term in October 2015. The company advises that the Board of Directors is expected to appoint an interim director to complete Crowder’s term.
A copy of the press release issued by the Registrant to announce the above is attached to this Current Report as Exhibit 99. This press release is being furnished to, as opposed to filed with, the Securities and Exchange Commission
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
Exhibit 99. Press Release issued by the Registrant on April 18, 2016
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEOGEN CORPORATION | ||||||
| (Registrant) | ||||||
| Date: April 19, 2016 |
||||||
| /s/ Steven J. Quinlan | ||||||
| Steven J. Quinlan | ||||||
| Vice President & CFO | ||||||
Exhibit 99
FOR IMMEDIATE RELEASE
| CONTACT: | Steven J. Quinlan, Neogen Vice President & CFO |
| 517/372-9200 |
Crowder resigns as Neogen director
LANSING, Mich., April 18, 2016 — Neogen Corporation (NASDAQ: NEOG) announced today that Dr. Richard Crowder has resigned as a member of the company’s Board of Directors, effective April 30. Crowder, 77, resigned for personal reasons.
Crowder has been a member of the Board of Directors since 2009 and was elected to a new three-year term in October 2015. The company advises that the Board of Directors is expected to appoint an interim director to complete Crowder’s term.
“Dick Crowder has been a great asset to the Board and a good advisor to me through his years with Neogen,” said James Herbert, Neogen’s chairman and CEO. “Ambassador Crowder brought a wealth of background and experience to our Board having served as United States Chief Agriculture Negotiator, Under Secretary of U.S. Department of Agriculture, and numerous corporate board memberships. Currently a member of the faculty at Virginia Tech University, Dr. Crowder has 40 years of experience in agriculture and trade industries. We certainly thank him for his service.”
Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.
###